Cover Image
市場調查報告書

移植的全球市場:2017∼2021年

Global Transplantation Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 324725
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
移植的全球市場:2017∼2021年 Global Transplantation Market 2017-2021
出版日期: 2017年04月26日 內容資訊: 英文 70 Pages
簡介

全球移植市場,預計2017∼2021年以9.76%的年複合成長率(CAGR) 成長。

本報告提供全球的內臟器官等的移植市場相關分析,技術概要和市場結構,市場規模趨勢 (今後5年的預測值),各產品種類、各地區的詳細趨勢,推動、阻礙市場要素與其影響力,主要企業簡介,今後的市場機會等調查、考察。

第1章 摘要整理

第2章 市場分析技術

第3章 簡介

第4章 市場形勢

  • 市場概況
  • 波特的五力分析

第5章 各產品種類的市場區隔

  • 移植用組織產品市場
  • 內臟器官保存溶液市場
  • 其他移植用產品市場
  • 移植診斷市場

第6章 各治療的市場區隔

  • 全球肝臟移植市場
  • 全球腎臟移植市場
  • 全球心臟移植市場
  • 全球肺移植市場
  • 全球胰臟移植市場
  • 世界其他地區的移植市場

第7章 各終端用戶的市場區隔

  • 醫院及移植中心
  • 捐贈者登記所及研究所

第8章 地區區分

  • 南北美洲市場
  • 歐洲、中東、非洲地區 (EMEA) 市場
  • 亞太地區市場

第9章 決策機構

第10章 促進市場成長的要素及課題

第11章 市場趨勢

第12章 供應商環境

  • 競爭方案

第13章 主要供應商分析

  • Bio-Rad Laboratories
  • Illumina
  • Thermo Fisher Scientific
  • 值得注意的企業
  • 其他著名的供應商

第14章 附錄

  • 簡稱集

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR11681

About Transplantation

Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.

Technavio's analysts forecast the global transplantation market to grow at a CAGR of 9.76% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global transplantation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products, which are used for treatment purposes.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Transplantation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bio-Rad Laboratories
  • Illumina
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Abbott Laboratories
  • Acelity
  • Avioq
  • AxoGen
  • BD
  • BioLifeSolutions
  • CARMAT
  • CareDx
  • Chronix Biomedical
  • Dr. Franz Kohler Chemie
  • GenDx
  • HistoGenetics
  • Luminex
  • Miromatrix Medical
  • Medipex
  • Nano Dimension
  • Organovo
  • Ortho Clinical Diagnostics
  • Oxford Immunotec
  • Pacific Biosciences of California
  • Pandorum Technologies
  • Qiagen
  • Roche
  • Siemens Healthineers
  • SynCardia
  • Transplant Biomedicals
  • XVIVO Perfusion

Market driver

  • M&A between small specialized hospitals and tier-1 hospitals.
  • For a full, detailed list, view our report

Market challenge

  • High cost of transplant and unfavorable reimbursement scenario.
  • For a full, detailed list, view our report

Market trend

  • Government initiatives on transplant research programs.
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Research Methodology

PART 03: Introduction

  • Key market highlights
  • Overview of organ transplantation
  • Overview of global transplantation market

PART 04: Market landscape

  • Market overview
  • Five forces analysis

PART 05: Market segmentation by product

  • Global transplantation market by tissue products
  • Global transplantation market by organ preservation solutions
  • Global transplantation market by other transplantation products
  • Global transplantation market by transplant diagnostics

PART 06: Market segmentation by procedures

  • Global kidney transplantation market
  • Global liver transplantation market
  • Global heart transplantation market
  • Global lung transplantation market
  • Global pancreas transplantation market
  • Global other transplantation market

PART 07: Market segmentation by end-user

  • Hospitals and transplant centers
  • Donor registries and research laboratories

PART 08: Geographical segmentation

  • Transplantation market in Americas
  • Transplantation market in EMEA
  • Transplantation market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 11: Market trends

  • Government initiatives on transplant research programs
  • Emergence of 3D bioprinting
  • Paradigm shift toward liquid biopsy
  • Increase in M&A

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • Bio-Rad Laboratories
  • Illumina
  • Thermo Fisher Scientific
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Kidney transplantation: Number of deceased and living donors in 2014
  • Exhibit 02: Liver transplantation: Number of deceased and living donors in 2014
  • Exhibit 03: Global transplantation market 2016-2021 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Market overview: Global transplantation market by tissue products
  • Exhibit 06: Global tissue products market 2016-2021 ($ billions)
  • Exhibit 07: Market overview: Global transplantation market by organ preservation solutions
  • Exhibit 08: Global transplantation market by organ preservation solutions 2016-2021 ($ millions)
  • Exhibit 09: Market overview: Global transplantation market by other transplantation products
  • Exhibit 10: Global transplantation market by other transplantation products 2016-2021 ($ billions)
  • Exhibit 11: Transplant diagnostics market: Serological testing and HLA typing 2016-2021 ($ millions)
  • Exhibit 12: Future focus: Transplant diagnostics market
  • Exhibit 13: Global HLA testing market 2016-2021 ($ millions)
  • Exhibit 14: Global serological testing market 2016-2021 ($ millions)
  • Exhibit 15: Global transplantation market segmentation by procedures in 2016
  • Exhibit 16: Market overview: Global kidney transplantation market
  • Exhibit 17: Market overview: Global liver transplantation market
  • Exhibit 18: Market overview: Heart transplantation
  • Exhibit 19: Global transplantation market by end-users 2016
  • Exhibit 20: Global transplantation market by geography 2016 and 2021 ($ billions)
  • Exhibit 21: Market overview: Transplantation market in Americas
  • Exhibit 22: Transplantation market in Americas 2016-2021 ($ billions)
  • Exhibit 23: Transplantation market in Americas: Market analysis of various countries
  • Exhibit 24: Types of transplants in US 2015
  • Exhibit 25: Market overview: Transplantation market in the US
  • Exhibit 26: Market overview: Transplantation market in Europe
  • Exhibit 27: Increase in number of donors for kidney transplantation in Europe 2010-2014
  • Exhibit 28: Transplantation market in EMEA 2016-2021 ($ billions)
  • Exhibit 29: Transplantation market in EMEA: Market analysis in various countries
  • Exhibit 30: Market overview: Transplantation market in UK
  • Exhibit 31: Market overview: Transplantation market in APAC
  • Exhibit 32: Transplantation market in APAC 2016-2021 ($ billions)
  • Exhibit 33: Transplantation market in APAC: Market analysis of various countries
  • Exhibit 34: Market overview: Transplantation market in Australia
  • Exhibit 35: Market impact analysis: Technology advances
  • Exhibit 36: Number of hospitals in US that were part of M&A 2010-2015
  • Exhibit 37: Impact of drivers
  • Exhibit 38: Average cost of transplantation procedures
  • Exhibit 39: Average cost of sequencers by different companies
  • Exhibit 40: People waiting for organ transplantation 2016
  • Exhibit 41: Complications specific to organs
  • Exhibit 42: Legal and ethical issues in countries
  • Exhibit 43: Impact of challenges
  • Exhibit 44: Competitive structure analysis of global transplantation market 2016
  • Exhibit 45: Competitive landscape of global transplantation market 2016
  • Exhibit 46: Strategies for large and small companies in global transplantation market
  • Exhibit 47: Bio-Rad Laboratories: Strength assessment
  • Exhibit 48: Bio-Rad Laboratories: Strategy assessment
  • Exhibit 49: Bio-Rad Laboratories: Opportunity assessment
  • Exhibit 50: Illumina: Strength assessment
  • Exhibit 51: Illumina: Strategy assessment
  • Exhibit 52: Illumina: Opportunity assessment
  • Exhibit 53: Thermo Fisher Scientific: Strength assessment
  • Exhibit 54: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 55: Thermo Fisher Scientific: Opportunity assessment
Back to Top